
SoftMining is an AI-powered drug discovery company focused on designing new molecules and materials for therapeutics. Their mission is to *in silico* generate molecules with desired properties to address unmet medical needs. Leveraging over 15 years of university research, they have integrated these findings into a comprehensive development platform. Their achievements include designing two new antibiotics, filing four patent applications, discovering a new biodegradable material for PVC replacement, advancing two molecules with antitumor activity into clinical trials (Phase II), and developing a novel chemical synthesis technique. Their platform offers tools like Arise for scientific literature search, Folden for protein structure prediction, Similis for ligand search, Matisse for binding pocket similarity, Flocking for lead optimization, Brevia for patent literature search, and Waterscope for binding energy estimation.

SoftMining is an AI-powered drug discovery company focused on designing new molecules and materials for therapeutics. Their mission is to *in silico* generate molecules with desired properties to address unmet medical needs. Leveraging over 15 years of university research, they have integrated these findings into a comprehensive development platform. Their achievements include designing two new antibiotics, filing four patent applications, discovering a new biodegradable material for PVC replacement, advancing two molecules with antitumor activity into clinical trials (Phase II), and developing a novel chemical synthesis technique. Their platform offers tools like Arise for scientific literature search, Folden for protein structure prediction, Similis for ligand search, Matisse for binding pocket similarity, Flocking for lead optimization, Brevia for patent literature search, and Waterscope for binding energy estimation.